ArticleClinical case reports2021
Acute macular neuroretinopathy as a manifestation of coronavirus disease 2019: A case report.
Article in Clinical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 21 citations in OpenAlex.
- Acute macular neuroretinopathy following COVID-19 infection: Three case reports.World journal of clinical cases · 2024Article
- Bilateral acute macular neuroretinopathy associated with COVID-19 infection presenting with central scotoma.American journal of ophthalmology case reports · 2024Article
- Acute macular neuroretinopathy and COVID-19 or SARS-CoV-2 infection: case report and literature review.Frontiers in medicine · 2024Article
- Outer Retinopathies Associated with COVID-19 Infection: Case Reports and Review of Literature.Case reports in ophthalmological medicine · 2024Article
- Ophthalmic Presentations and Manifestations of COVID-19: A Systematic Review of Global Observations.Cureus · 2023Review
- Recurring nodular scleritis following inactivated vaccination for COVID-19.Clinical case reports · 2023Article
- [Paracentral scotomas associated with COVID-19 infection].Die Ophthalmologie · 2023Article
- Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy during SARS-CoV-2 Infection and Vaccination.Vaccines · 2023Article
- Case Report: Acute Macular Neuroretinopathy Which Led to COVID-19 Infection Diagnosis.Beyoglu eye journal · 2023Article
- COVID-19 and Acute Macular Neuroretinopathy - An underlying association?Annals of medicine and surgery (2012) · 2022Article
- Paracentral acute middle maculopathy and COVID-19 vaccination: Causation versus coincidence finding.Clinical case reports · 2022Article
- Acute macular neuroretinopathy as a manifestation of coronavirus disease 2019: A case report.Clinical case reports · 2021Article
- Non-invasive brain microcurrent stimulation therapy of long-COVID-19 reduces vascular dysregulation and improves visual and cognitive impairment.Restorative neurology and neuroscience · 2021Article
- Choroidal Circulatory and Vascular Morphological Changes in Acute Macular Neuroretinopathy After Infection With Severe Acute Respiratory Syndrome Coronavirus 2: A Case Report With Literature Review.In vivo (Athens, Greece)Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The current findings is important in raising clinicians' awareness of the possibility of coincident acute macular neuroretinopathy (AMN) and COVID-19 as a potential cause of retinal vascular damage and ischemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.